Compare ARK Genomic Revolution ETF (ARKG) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Consumer Staples Select Sector SPDR Fund — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Consumer Staples Select Sector SPDR Fund trades at $84.41. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ARKG | XLP | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $90.00 |
52-Week Low | $23.09 | $75.61 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XLP trades at $84.12, up 1.11% with a bearish technical signal despite neutral oscillators. The ETF maintains strong analyst support with 100% buy ratings and offers defensive exposure to consumer staples. Recent news highlights XLP's role as a safe haven during market uncertainty, with a 2.6% dividend yield providing income stability amid economic pressures.
The fund's defensive positioning and high dividend yield present opportunity during market volatility, though concentration in 36 holdings increases single-stock risk. Technical weakness suggests near-term pressure, but long-term fundamentals remain sound for investors seeking stable consumer staples exposure with income generation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
